Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
Allison M. Owen, Jessica B. Fults, Naeem K. Patil, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Pattern recognition receptors in health and diseases
Danyang Li, Minghua Wu
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1077
Toll-Like Receptors: General Molecular and Structural Biology
Payam Behzadi, Herney Andrés García‐Perdomo, Tomasz M. Karpiński
Journal of Immunology Research (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 176
Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use
Anna Skrzypczak-Wiercioch, Kinga Sałat
Molecules (2022) Vol. 27, Iss. 17, pp. 5481-5481
Open Access | Times Cited: 158
Human NK cells, their receptors and function
Linda Quatrini, Mariella Della Chiesa, Simona Sivori, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1566-1579
Open Access | Times Cited: 124
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 85
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Wenxuan Ren, Lei Zhao, Ying Sun, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 47
An Overview of the Recent Advances in Antimicrobial Resistance
Manuela Oliveira, Wilson Antunes, S. R. F. MOTA, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1920-1920
Open Access | Times Cited: 29
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Immune activities of polysaccharides isolated from Lycium barbarum L. What do we know so far?
Zhiyong Xiao, Qi Deng, Wenxia Zhou, et al.
Pharmacology & Therapeutics (2021) Vol. 229, pp. 107921-107921
Closed Access | Times Cited: 94
MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages
Allison M. Owen, Liming Luan, Katherine R. Burelbach, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 40
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 39
Outer Membrane Vesicle‐Based Nanohybrids Target Tumor‐Associated Macrophages to Enhance Trained Immunity‐Related Vaccine‐Generated Antitumor Activity
Jie Liang, Fei Zhu, Keman Cheng, et al.
Advanced Materials (2023) Vol. 35, Iss. 46
Closed Access | Times Cited: 30
Weight cycling induces innate immune memory in adipose tissue macrophages
Heather L. Caslin, Matthew A. Cottam, Jacqueline M. Piñon, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 29
PD1-TLR10 fusion protein enhances the antitumor efficacy of CAR-T cells in colon cancer
Yuzheng Peng, Zhiming Huang, Yafei Wu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114083-114083
Closed Access | Times Cited: 1
Oligodendroglial precursor cells modulate immune response and early demyelination in a murine model of multiple sclerosis
Qi Wang, Taida Huang, Zihan Zheng, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 792
Closed Access | Times Cited: 1
Development of Exhausted Memory Monocytes and Underlying Mechanisms
Kisha Pradhan, Ziyue Yi, Shuo Geng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
Prevention and treatment of human papillomavirus in men benefits both men and women
Kangni Zou, Yue Huang, Zhengyu Li
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 36
HIV and cardiovascular disease: the role of inflammation
Sahera Dirajlal‐Fargo, Nicholas Funderburg
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 5, pp. 286-292
Open Access | Times Cited: 31
The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
Аlbert R. Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14820-14820
Open Access | Times Cited: 20
Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential
Ming Yao Ho, Songhan Liu, Bengang Xing
Nano Convergence (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
Fen Xiao, Zhibin Wang, Qiao Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama–Kohara
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10462-10462
Open Access | Times Cited: 39
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
Shetty Ravi Dyavar, Rahul Singh, Rohini Emani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111794-111794
Open Access | Times Cited: 38
New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19
Yára Dadalti Fragoso, Sidney Gomes, Marcus Vinícius Magno Gonçalves, et al.
Multiple Sclerosis and Related Disorders (2021) Vol. 57, pp. 103321-103321
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top